CME/CE Activity Sorter
(Select therapeutic category and activity type of interest and view your sorted activities below)

Your Sorted CME/CE Activities

Number of search result: 43

Conversations in High-Risk Non-Muscle Invasive Bladder Cancer

Conversations in High-Risk Non-Muscle Invasive Bladder Cancer

Talking Hemophilia A:  Integrating Novel Treatments and Enhancing Patient Outcomes

Talking Hemophilia A: Integrating Novel Treatments and Enhancing Patient Outcomes

Conversations and Cases: Integrating Recent Progress in the Treatment and Management of Relapsed Refractory Multiple Myeloma

Conversations and Cases: Integrating Recent Progress in the Treatment and Management of Relapsed Refractory Multiple Myeloma

Conversations and Updates in Myelodysplastic Syndromes:  Practice-Changing Expert Insights in Lower- and Higher-Risk MDS

Conversations and Updates in Myelodysplastic Syndromes: Practice-Changing Expert Insights in Lower- and Higher-Risk MDS

Practice-Changing Updates in the Second-Line Treatment of Gastric/GEJ Cancer (2 of 2)

Practice-Changing Updates in the Second-Line Treatment of Gastric/GEJ Cancer (2 of 2)

Practice-Changing Updates in the First-Line Treatment of Gastric/GEJ Cancer (1 of 2)

Practice-Changing Updates in the First-Line Treatment of Gastric/GEJ Cancer (1 of 2)

Lightning Reports™ from ASH 2022 on Low and High-Risk MDS

Lightning Reports™ from ASH 2022 on Low and High-Risk MDS

Conversations and Updates in Gastric/GEJ Cancer: Practice-Changing Expert Insights to Improve Outcomes

Conversations and Updates in Gastric/GEJ Cancer: Practice-Changing Expert Insights to Improve Outcomes

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse: A CME Webcast Series*

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse: A CME Webcast Series*

Talking Multiple Myeloma: Strategies to Treat and Manage Patients in the Frontline and Beyond

Talking Multiple Myeloma: Strategies to Treat and Manage Patients in the Frontline and Beyond

Conversations in Oncology: Updates in the Treatment of Early Non-Small Cell Lung Cancer

Conversations in Oncology: Updates in the Treatment of Early Non-Small Cell Lung Cancer

Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Improving Outcomes of Frontline Treatment and Mitigating Relapse

Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Improving Outcomes of Frontline Treatment and Mitigating Relapse

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia - Updated 8/18/2022

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia - Updated 8/18/2022

Lightning Reports™ from ASCO 2022: Bladder Cancer

Lightning Reports™ from ASCO 2022: Bladder Cancer

Lightning Reports™ from ASCO 2022: Targeted Therapy in Lung Cancer

Lightning Reports™ from ASCO 2022: Targeted Therapy in Lung Cancer

Independent Conference Coverage from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting*

Independent Conference Coverage from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting*

Diagnostic Considerations for Optimizing Successful Outcomes in Hemophagocytic Lymphohistiocytosis

Diagnostic Considerations for Optimizing Successful Outcomes in Hemophagocytic Lymphohistiocytosis

Hot Topics on Relapsed/Refractory Multiple Myeloma from the 63rd ASH Annual Meeting*

Hot Topics on Relapsed/Refractory Multiple Myeloma from the 63rd ASH Annual Meeting*

Hot Topics on CAR T- Cell Therapy from the 63rd ASH Annual Meeting*

Hot Topics on CAR T- Cell Therapy from the 63rd ASH Annual Meeting*

Hot Topics on Low-Risk Myelodysplastic Syndromes (MDS) from the 63rd ASH Annual Meeting*

Hot Topics on Low-Risk Myelodysplastic Syndromes (MDS) from the 63rd ASH Annual Meeting*